Form D — NurExone Biologic Inc.
0001995074-26-000004 · filed Aug 21, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $450,456
- Reported amount sold
- $450,456
- Minimum investment
- $0
- Investors
- 2
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- NurExone Biologic Inc.
- CIK
- 1995074
- Entity
- Corporation
- Jurisdiction
- ONTARIO, CANADA
- Year incorporated
- 2025
- Address
- MINUS 1 ENTRY, GROUND FLOOR OF BLDG B
TECHNION CITY, HAIFA, L3 3200003 - Phone
- 972 52-4803034
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Lior Shaltiel · Executive OfficerTechnion City, Haifa, L3 Find on LinkedIn ↗
-
Eran Ovadya · Executive OfficerTechnion City, Haifa, L3 Find on LinkedIn ↗
-
Yoram Drucker · Executive OfficerTechnion City, Haifa, L3 Find on LinkedIn ↗
-
Oded Orgil · DirectorTechnion City, Haifa, L3 Find on LinkedIn ↗
-
David Stolick · DirectorTechnion City, Haifa, L3 Find on LinkedIn ↗
-
Eyal Gabbai · DirectorTechnion City, Haifa, L3 Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗